United Kingdom (UK) Parkinsons Disease Market (2025-2031) | Value, Forecast, Share, Growth, Segmentation, Trends, Industry, Competitive Landscape, Outlook, Size & Revenue, Analysis, Companies

Name: United Kingdom (UK) Parkinsons Disease Market (2025-2031) | Value & Forecast
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Drug Class (Levodopa/Carbidopa, Dopamine Receptor Agonists, MAO-Inhibitors, COMT-Inhibitors, Anticholinergics, Other Drugs), By Medical Devices (Deep Brain Stimulation (DBS) Devices, Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices), By Route of Administration (Oral, Transdermal, Subcutaneous, Intestinal Infusion, Others), By Distribution Channel (Hospital Pharmacies, Clinics, Retail Pharmacies, Online Pharmacies), By Patient Care Setting (Hospitals, Clinics) And Competitive Landscape

Product Code: ETC9951253	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Summon Dutta	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United Kingdom (UK) Parkinsons Disease Market Outlook
Market Size of United Kingdom (UK) Parkinsons Disease Market, 2024
Forecast of United Kingdom (UK) Parkinsons Disease Market, 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Revenues & Volume for the Period 2021- 2031
United Kingdom (UK) Parkinsons Disease Market Trend Evolution
United Kingdom (UK) Parkinsons Disease Market Drivers and Challenges
United Kingdom (UK) Parkinsons Disease Price Trends
United Kingdom (UK) Parkinsons Disease Porter's Five Forces
United Kingdom (UK) Parkinsons Disease Industry Life Cycle
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Drug Class for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Levodopa/Carbidopa for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Dopamine Receptor Agonists for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By MAO-Inhibitors for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By COMT-Inhibitors for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Anticholinergics for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Other Drugs for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Medical Devices for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Deep Brain Stimulation (DBS) Devices for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Route of Administration for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Oral for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Transdermal for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Subcutaneous for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Intestinal Infusion for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Hospital Pharmacies for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Clinics for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Retail Pharmacies for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Online Pharmacies for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Patient Care Setting for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Hospitals for the Period 2021- 2031
Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Clinics for the Period 2021- 2031
United Kingdom (UK) Parkinsons Disease Import Export Trade Statistics
Market Opportunity Assessment By Drug Class
Market Opportunity Assessment By Medical Devices
Market Opportunity Assessment By Route of Administration
Market Opportunity Assessment By Distribution Channel
Market Opportunity Assessment By Patient Care Setting
United Kingdom (UK) Parkinsons Disease Top Companies Market Share
United Kingdom (UK) Parkinsons Disease Competitive Benchmarking By Technical and Operational Parameters
United Kingdom (UK) Parkinsons Disease Company Profiles
United Kingdom (UK) Parkinsons Disease Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United Kingdom (UK) Parkinsons Disease Market Overview

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Parkinsons Disease Market - Industry Life Cycle

3.4 United Kingdom (UK) Parkinsons Disease Market - Porter's Five Forces

3.5 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F

3.7 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

3.9 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F

4 United Kingdom (UK) Parkinsons Disease Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing aging population in the UK

4.2.2 Advances in medical research leading to better understanding and treatment of Parkinson's disease

4.2.3 Rising awareness and education about Parkinson's disease among healthcare professionals and the general public

4.3 Market Restraints

4.3.1 High costs associated with Parkinson's disease treatment and management

4.3.2 Limited accessibility to specialized healthcare services in certain regions of the UK

4.3.3 Potential side effects and risks associated with current Parkinson's disease medications

5 United Kingdom (UK) Parkinsons Disease Market Trends

6 United Kingdom (UK) Parkinsons Disease Market, By Types

6.1 United Kingdom (UK) Parkinsons Disease Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F

6.1.4 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F

6.1.5 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F

6.1.6 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F

6.1.7 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F

6.1.8 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F

6.2 United Kingdom (UK) Parkinsons Disease Market, By Medical Devices

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F

6.2.3 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F

6.3 United Kingdom (UK) Parkinsons Disease Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F

6.3.4 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F

6.3.5 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F

6.3.6 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F

6.4 United Kingdom (UK) Parkinsons Disease Market, By Distribution Channel

6.4.1 Overview and Analysis

6.4.2 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.4.3 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.4 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.4.5 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F

6.5 United Kingdom (UK) Parkinsons Disease Market, By Patient Care Setting

6.5.1 Overview and Analysis

6.5.2 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.3 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F

7 United Kingdom (UK) Parkinsons Disease Market Import-Export Trade Statistics

7.1 United Kingdom (UK) Parkinsons Disease Market Export to Major Countries

7.2 United Kingdom (UK) Parkinsons Disease Market Imports from Major Countries

8 United Kingdom (UK) Parkinsons Disease Market Key Performance Indicators

8.1 Number of clinical trials and research studies focused on Parkinson's disease in the UK

8.2 Percentage increase in early diagnosis rates of Parkinson's disease

8.3 Adoption rate of new Parkinson's disease treatment guidelines by healthcare providers

9 United Kingdom (UK) Parkinsons Disease Market - Opportunity Assessment

9.1 United Kingdom (UK) Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 United Kingdom (UK) Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F

9.3 United Kingdom (UK) Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 United Kingdom (UK) Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

9.5 United Kingdom (UK) Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F

10 United Kingdom (UK) Parkinsons Disease Market - Competitive Landscape

10.1 United Kingdom (UK) Parkinsons Disease Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Colombia Parkinsons Disease Market

Czech Republic Parkinsons Disease Market

Egypt Parkinsons Disease Market

France Parkinsons Disease Market

Georgia Parkinsons Disease Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here